CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
51.42
-2.84 (-5.23%)
At close: Oct 30, 2026, 4:00 PM EDT
51.54
+0.12 (0.23%)
After-hours: Oct 30, 2026, 7:57 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.97 billion as of October 30, 2026. It is the 3,562nd most valuable company in the world and the 1,163rd biggest in the United States. Its market cap has decreased by 12.62% in one year.
Market Cap
4.97B
Enterprise Value
3.39B
1-Year Change
-12.62%
Global Rank
Country Rank
#1,163 United States
Category
ChartMarket Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.97B, an increase of 787.69%. That is a compound annual growth rate of 24.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 4.97B | -0.51% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 5.84B |
| CG Oncology | 5.73B |
| Mirum Pharmaceuticals | 5.52B |
| Cogent Biosciences | 5.38B |
| Scholar Rock Holding | 5.35B |
| Erasca | 5.02B |
| PTC Therapeutics | 5.01B |
| Definium Therapeutics | 4.88B |